Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO 2019 /
No difference in survival between laparoscopic surgery and open surgery in colorectal cancer patients with liver metastases

31st May - 4th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.06.19
Views: 256
Rating:

Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway

Dr Åsmund Fretland presents results at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting from the OSLO-COMET trial.

This was a randomised trial in which colorectal cancer patients with liver metastases were randomly assigned to either laparoscopic surgery or open surgery.

It was found that using laparoscopic surgery did not reduce chances of survival, with patients living a median 80 months after surgery compared with 81 months for patients who underwent open surgery.

Watch the interview here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation